IFNA1 and multiple sclerosis: Human studies have documented in vivo production of IFN antibodies following treatment for a variety of conditions including hepatitis C [20, 21], multiple sclerosis [22], midgut carcinoid tumors [23], and hairy cell leukemia [24].